NCT/Study#
NCT05533697 /
MRNA-4359-P101
Phase I/II clinical study of mRNA-4359 Administered Alone or in Combination with Immune Checkpoint Blockade in Participants with Advanced Solid Tumors.
DISEASE GROUP:
Advanced Solid Tumors
current phase:
Phase II/III
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
